The PERK pathway: beneficial or detrimental for neurodegenerative diseases and tumor growth and cancer
Human Molecular Genetics · 2023
DOI: 10.1093/hmg/ddad103 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Human Molecular Genetics, 2023. Verfasst von Gourango Talukdar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Translational Neuroscience and Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Protein kinase R (PKR)-like endoplasmic reticulum (ER) kinase (PERK) is one of the three major sensors in the unfolded protein response (UPR). The UPR is involved in the modulation of protein synthesis as an adaptive response. Prolonged PERK activity correlates with the development of diseases and the attenuation of disease severity. Thus, the current debate focuses on the role of the PERK signaling pathway either in accelerating or preventing diseases such as neurodegenerative diseases, myelin disorders, and tumor growth and cancer. In this review, we examine the current findings on the PERK signaling pathway and whether it is beneficial or detrimental for the above-mentioned disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute for Translational Neuroscience and Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA.
- Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA.
- Department of Neuroscience, University of Minnesota, Minneapolis, MN 55455, USA.
ORCID-Profile: Gourango Talukdar
Förderung
- NINDS NIH HHS
- National Institutes of Health
Zitieren
APA
Talukdar, G., Orr, H. T., & Lei, Z. (2023). The PERK pathway: beneficial or detrimental for neurodegenerative diseases and tumor growth and cancer. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddad103
Vancouver
Talukdar G, Orr HT, Lei Z. The PERK pathway: beneficial or detrimental for neurodegenerative diseases and tumor growth and cancer. Human Molecular Genetics. 2023. doi:10.1093/hmg/ddad103
BibTeX
@article{Talukdar2023,
author = {Talukdar, Gourango and Orr, Harry T and Lei, Zhixin},
title = {The PERK pathway: beneficial or detrimental for neurodegenerative diseases and tumor growth and cancer},
journal = {Human Molecular Genetics},
year = {2023},
doi = {10.1093/hmg/ddad103}
}
EUVIMED